Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. - Wikidata - wikimedia - TriplyDB

Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.

Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.

http://www.wikidata.org/entity/Q35258324

about

Nitric oxide and pH modulation in gynaecological cancer Redox regulation of ischemic limb neovascularization - What we have learned from animal studies The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription.L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo.Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis.The Daniel K. Inouye College of Pharmacy Scripts: Poha Berry (Physalis peruviana) with Potential Anti-inflammatory and Cancer Prevention Activities Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NFκB and nitric oxide pathways Do signal transduction cascades influence survival in triple-negative breast cancer? A preliminary study.Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.Lentinan protects pancreatic β cells from STZ-induced damage.Gasotransmitters in cancer: from pathophysiology to experimental therapy.Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment.Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer.Role of RPL39 in Metaplastic Breast Cancer.Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.The EMT spectrum and therapeutic opportunities.Targeted inhibition of endoplasmic reticulum stress: New hope for renal fibrosis (Review)Significance of twist and iNOS expression in human breast carcinoma.Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid Leukemia Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer.Cytoglobin Promotes Cardiac Progenitor Cell Survival against Oxidative Stress via the Upregulation of the NFκB/iNOS Signal Pathway and Nitric Oxide Production.Ethanol extract of propolis and its constituent caffeic acid phenethyl ester inhibit breast cancer cells proliferation in inflammatory microenvironment by inhibiting TLR4 signal pathway and inducing apoptosis and autophagy.MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1.Targeting iNOS to increase efficacy of immunotherapies.Splice variants of cytosolic polyadenylation element-binding protein 2 (CPEB2) differentially regulate pathways linked to cancer metastasis.Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways.Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication.Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation.NO and COX2: Dual targeting for aggressive cancers.The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis.Glioma and microglia, a double entendre.Total Flavonoids from Radix Glycyrrhiza Exert Anti-Inflammatory and Antitumorigenic Effects by Inactivating iNOS Signaling Pathways.Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models Polycationic carbosilane dendrimer decreases angiogenesis and tumor-associated macrophages in tumor-bearing mice iNOS promotes CD24CD133 liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway

P2860

Q26741063-F6859CAD-1190-426C-B45E-25A1E7B16356 Q33681553-ED3E066F-182F-4BE5-8345-A070B3E1F68B Q35819880-C0842931-BCE0-4EA4-A8B5-FD7BCB13FA97 Q36035570-EC46E4B3-2598-45B6-8E79-F8F84313A6DB Q36090325-5F51E713-6EB0-465C-95B9-CCA9AD507CCA Q36213996-729D01B5-BFA9-452A-B82C-8486F384A268 Q36457669-65EE77A2-54A2-442D-8E10-09F8CBC6CBA0 Q36592001-B422B83D-3B62-4AF8-B3EC-80C6F73F2472 Q36955641-5289A095-178E-4D05-AD87-F572E439BE15 Q37014210-8367B0F4-442B-478A-952E-3505A54BD39A Q37251605-7A10B6E2-8BCE-4B06-B54E-0BE1618E3A3A Q37656625-5F4F41E4-FB31-4690-AA99-E492BB4A5480 Q37718207-C5EDA9A7-12BE-410E-9B3B-2E1F7029CD49 Q37720884-447B8F1A-7EC6-4AC1-835C-2F7DA611A65A Q38723382-21945DCD-FD82-408B-A805-1DF0DAADEC55 Q38837269-EF5B602B-42AD-46BD-8546-04DC00B4BCCD Q38953498-E7828226-56E2-4083-8CD5-0BE558ED850C Q39329818-A9DBA393-AA2F-402C-8BFE-D119FF2C7017 Q39382387-B1FD0D57-0FFA-4C3E-AD97-C03B8D66589E Q40294423-CD7BF088-6E80-4FBF-BA6F-8A0280939AA2 Q41089780-B419F548-C246-4052-88AD-04FB28CF6C2B Q41225554-1AF86905-CB1B-4F98-B1DA-E2FC86B385CF Q41540397-32012F88-1A62-4200-ABF3-D0FCDF5365ED Q41670315-F61357E3-E79A-4574-AB91-9CE251AAC575 Q42630303-A33E8FA9-CBBF-486C-A739-D14C9C02252C Q43024830-3E6A5B82-6118-4CDF-B215-FF49CB5CB7D6 Q45067339-BD799B8B-CC64-4903-9915-B170ADA02103 Q45412843-BC2EF868-EF14-4021-A2D9-A090037BD0BD Q47105736-0C747AEC-B8F5-4CB2-8D82-D4FC75CDA391 Q47315412-281C2A09-0B18-44DF-B9F7-53573D62E22B Q47711103-DD3BF97A-DB38-4D78-A12B-C937F8EC394A Q48122606-E89D123B-F79C-4FB5-ACC7-32C515FC15F4 Q49346285-3209781C-274D-4352-B37F-ECE6BD67C31C Q49544289-605C8BE5-8330-4FFA-9404-679D369DA991 Q52362244-2647CB3C-FDE0-431C-8A37-3BC086CDB392 Q53824336-04ACC671-E3DE-43DA-962B-1B8D8A0BDC8F Q55333957-48568883-6190-42F1-95E9-5212EB03EC7B Q56889140-29B9901B-1673-442E-94DF-3EE812945348 Q57079914-070325C2-0C7C-45A0-ADBE-B238FA2053BE Q57295964-9D2D3259-1483-4165-8DB6-82AD0F6780AD

P2860

Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.

http://www.wikidata.org/entity/Q35258324

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Inhibition of iNOS as a novel ...... triple-negative breast cancer.

@ast

Inhibition of iNOS as a novel ...... triple-negative breast cancer.

@en

type

label

Inhibition of iNOS as a novel ...... triple-negative breast cancer.

@ast

Inhibition of iNOS as a novel ...... triple-negative breast cancer.

@en

prefLabel

Inhibition of iNOS as a novel ...... triple-negative breast cancer.

@ast

Inhibition of iNOS as a novel ...... triple-negative breast cancer.

@en

P1433

Q35258324-741F8306-4631-432F-8E66-EF912615F22D

P1476

Q35258324-80F134F2-D3A8-41C1-8ABF-B4826B096F93

P2093

Q35258324-1F16D419-4FF3-48CB-A7DA-DBA575E71286

Q35258324-2FCBE84C-08C7-4F71-87FA-9D30BFBCFC7A

Q35258324-5885950F-9227-4538-9FA9-7D2CEFEC50CF

Q35258324-833553D8-E750-460D-9FB5-C92B49335452

Q35258324-8E5A7F26-FEEA-434D-A7A8-A2086B062F15

Q35258324-AF4AE051-B7EB-4D69-AB1C-997EE4EE2814

Q35258324-E7C3CDCA-A84E-442B-9D80-E943E87B81FC

Q35258324-F2B3B3A6-88D1-456D-8D62-6226790D4C73

Q35258324-F3DFFBC6-7072-445C-8FC5-C796A9811075

Q35258324-F86E1E2A-4472-4FF8-80FE-3AF72AB16710

P2860

Q35258324-0B97F7B8-6032-41AB-AC8C-1982CD63E073

Q35258324-0C5C421B-A862-4B89-95CA-9FF5C2470F82

Q35258324-150CE492-6C0C-4B59-95CF-A79DE6799CC1

Q35258324-1BB99F2D-095A-4E55-B04E-D449B61A7876

Q35258324-1CA5F50B-B8DE-4411-9758-576FA6145837

Q35258324-276E0F5E-5723-4756-9F5A-EA039C24C861

Q35258324-2F3B2D84-CFEA-4A23-99E4-89F5A49A76EA

Q35258324-380B9594-58D9-4639-B702-D36AAFC89A60

Q35258324-3D37556A-706C-467E-9203-3E93BDCD120A

Q35258324-40279E8D-65BB-4973-B0F3-AEC824C0A09A

P2888

Q35258324-8ADFB464-5FA8-44D7-84B0-B32D535C6AD5

P304

Q35258324-917C5284-B3F4-4779-8095-EA023D608F28

P31

Q35258324-35AA4689-D1DB-4DDC-8AA8-0C8EF96F60C9

P356

Q35258324-BBF0F5BE-6D4C-4D30-8F6D-772E35C78076

P478

Q35258324-3283ED72-CD48-4E59-9955-D7580FDBE19D

P50

Q35258324-7FF87A2E-F956-4F8A-AAAC-6EB29EE4D292

Q35258324-C41F2D7B-0BAB-4BB5-8945-D182486D5594

Q35258324-C74EA89C-D216-4694-A25D-DB16B0E539AC

P577

Q35258324-6AAA93DE-F2E8-40F0-99C1-077FF38D2ECB

P5875

Q35258324-E944137C-9EF3-4931-BA8E-B7ACCE5B6FFD

P6179

Q35258324-7B97BF33-4126-45D3-AAB7-3892FC3A2C9D

P698

Q35258324-9DD6CEEF-C5A0-40C6-8BE2-7BE0400F5B89

P932

Q35258324-35192425-84F8-430F-B600-03D7CA39ECFD

P356

S13058-015-0527-X

P1433

Breast Cancer Research

P1476

Inhibition of iNOS as a novel ...... triple-negative breast cancer.

@en

P2093

Bhuvanesh Dave

http://www.w3.org/2001/XMLSchema#string

Dong Soon Choi

http://www.w3.org/2001/XMLSchema#string

Elvin Blanco

http://www.w3.org/2001/XMLSchema#string

Heidi L Weiss

http://www.w3.org/2001/XMLSchema#string

Hong Zhao

http://www.w3.org/2001/XMLSchema#string

Joseph Cusimano

http://www.w3.org/2001/XMLSchema#string

Maria L Guevara

http://www.w3.org/2001/XMLSchema#string

Melissa D Landis

http://www.w3.org/2001/XMLSchema#string

Steven S Gross

http://www.w3.org/2001/XMLSchema#string

Tejal Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response

Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2

Epithelial-mesenchymal transitions in development and disease

A gene-expression signature as a predictor of survival in breast cancer

Untargeted plasma metabolite profiling reveals the broad systemic consequences of xanthine oxidoreductase inactivation in mice

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

A restricted cell population propagates glioblastoma growth after chemotherapy

Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.

P2888

s13058-015-0527-x

P304

25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13058-015-0527-X

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Angel A Rodriguez

Sergio Granados-Principal

P577

2015-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273506624

http://www.w3.org/2001/XMLSchema#string

P6179

1033791105

http://www.w3.org/2001/XMLSchema#string

P698

25849745

http://www.w3.org/2001/XMLSchema#string

P932

4384389

http://www.w3.org/2001/XMLSchema#string